NCT06246084View on ClinicalTrials.gov

INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

December 23, 2024

Conditions
Breast CancerBreast Cancer FemaleBreast Carcinoma
Interventions
BEHAVIORAL

Endocrine Therapy Education Program

Brief, video-based intervention program to improve endocrine therapy adherence and experiences and to provide detailed education to participants. The intervention is distributed and assessed via the MyEmma platform, a HIPAA-compliant, online communications platform.

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT06246084 - INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy | Biotech Hunter | Biotech Hunter